Answers from the Lab
312 episodes - English - Latest episode: 20 days ago -A Mayo Clinic curated podcast sharing Mayo Clinic knowledge and advancements on the state of testing, science, and people who are making it happen behind the scenes.
Homepage Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
Chromosomal microarray better informs brain tumor diagnosis: Robert Jenkins, M.D., Ph.D.
February 21, 2023 07:00 - 23 minutes - 33 MB(00:31) Could you provide a little bit about yourself and your background? (02:04) Could you provide an overview of the chromosomal microarray assay? (05:49) Why should the chromosomal microarray assay be used over other available assays, such as FISH? (08:56) Does the chromosomal microarray provide good benefits in terms of gain of 7 and loss of 10, and EGFR amplification? (12:03) What's the value of utilizing the test alongside a neuro-specific NGS panel, such...
When to test for norovirus: Dr. Bill Morice
February 16, 2023 07:00 - 9 minutes - 13.6 MBNorovirus is the No. 1 cause of foodborne illness in the United States. And while most people who contract norovirus recover on their own without the need for testing or treatment, others do not. In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, and William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, discuss what’s behind recent outbreaks of norovirus and how to...
THCU: Paul Jannetto, Ph.D., and Loralie Langman, Ph.D.
February 14, 2023 07:11 - 9 minutes - 13.8 MB(00:31): Before we get started, can you tell us a little bit about yourselves and your backgrounds? (02:35): Can you guys give us a brief overview of this assay and what will be changing to characterize marijuana use? (04:28): So which patients should have this testing and when would you say it should be performed, Dr. Langman? (05:58): Are there other test options available and if, and if so, how do these compare? (07:03): This is really the best way to accurately characterize...
Sharing Mayo Clinic knowledge globally while learning from other cultures: Dr. Bill Morice
February 09, 2023 07:00 - 9 minutes - 13.1 MBWilliam Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories , joins “Answers From the Lab” for his weekly leadership update with host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic. In this episode, Dr. Morice and Dr. Pritt discuss laboratory medicine from an international perspective: what advances are being made, how we educate future practitioners, and the need for global collaboration.
Novel biomarkers added to movement disorders profile: Andrew McKeon, M.B., B.Ch., M.D.
February 07, 2023 07:11 - 21 minutes - 29.9 MB(00:32) Can you tell our audience a little bit about yourself and your role here at Mayo Clinic? (01:29) Can you tell our listeners a little bit about the disease state when we talk about autoimmune or paraneoplastic movement disorders? (02:37) Are we seeing an increased prevalence of autoimmune movement disorders? (04:00) Can you give our listeners an overview of what's going to be launched here in January? (06:56) What other antibodies are particularly important in this p...
How digital pathology is changing patient care at Mayo Clinic: Dr. Joaquin Garcia
February 02, 2023 07:00 - 18 minutes - 25.4 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, sits down with Joaquin Garcia, M.D., chair of Mayo Clinic’s Division of Anatomic Pathology and digital pathology program to discuss how the advent of digital pathology is changing patient care at Mayo Clinic.
New gene panel enhances brain tumor profiles: Cristiane (Cris) Ida, M.D.
January 31, 2023 07:36 - 13 minutes - 18.2 MB(00:31) Could you provide our listeners with a little bit about yourself and your background? (01:48) Could you give an overview of the new neuro-oncology expanded gene panel by next generation sequencing? (03:43) Can you describe a little bit more about some examples of genes that were in the 2021 WHO classification that are now included in the NONCP panel? (06:50) Does this panel have high clinical utility in both in adult and pediatric cases? (08:05) Is picking ...
Triple-demic update and the future of at-home testing: Dr. Bill Morice
January 26, 2023 07:00 - 9 minutes - 13.2 MBIn this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., and William Morice II, M.D., Ph.D., provide an update on this year’s triple-demic of respiratory viruses, discuss the future of at-home testing, and preview future pandemic preparedness efforts.
Recap of this year’s J.P. Morgan Healthcare Conference and COVID-19 update: Dr. Bill Morice
January 19, 2023 07:00 - 10 minutes - 13.9 MBWilliam Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, joins “Answers From the Lab” for his weekly leadership update with host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic. In this episode, Dr. Morice shares his biggest takeaways from this year’s J.P. Morgan Healthcare Conference in San Francisco, California, and gives an update on the COVID-19 public health emergency.
Novel panel identifies toxins linked to asthma and GI diseases: Melissa Snyder, Ph.D.
January 17, 2023 07:00 - 7 minutes - 10.3 MB(00:32) Could you provide us with a little bit of your background? (01:12) Could you give us an overview of this test and a summary of the assay? (01:40) What kind of patients should expect to have this test ordered? (04:11) Are other tests available that identify EDN activation in patients? (05:11) How do you envision physicians using this test to treat patients? (06:32) Can you expand on how the test is used in patient treatment?
Legislative update and at-home testing: Dr. Bill Morice
January 12, 2023 09:00 - 10 minutes - 14.5 MBWilliam Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, joins Bobbi Pritt, M.D., on this week’s episode of the "Answers From the Lab" podcast. In this episode, they kick off the new year with a legislative update and discuss at-home testing options in the wake of the new subvariant of COVID-19.
Why cancer death rates are declining: Dr. Ansell
January 05, 2023 07:00 - 6 minutes - 9.57 MBSteven Ansell, M.D., Ph.D., chair of the Division of Hematology and senior deputy director, Midwest, Mayo Clinic Comprehensive Cancer Center, joins the "Answers From the Lab" podcast for a discussion with host Bobbi Pritt, M.D., about declining cancer death rates. In this episode, Dr. Ansell and Dr. Pritt discuss advancements in cancer treatments that are leading to declining death rates, the role diagnostics plays in cancer treatment, and what the future may hold for cancer diagnost...
Respiratory virus update and a new measles test: Dr. Matthew Binnicker
December 29, 2022 07:27 - 12 minutes - 17.7 MBMatthew Binnicker, Ph.D., director of the Clinical Virology Laboratory at Mayo Clinic, joins host Bobbi Pritt, M.D., on this week’s episode of the "Answers From the Lab" podcast. In this episode, they discuss the ongoing respiratory virus season, a new test for measles available at Mayo Clinic Laboratories, and some tips to stay healthy.
Predictions for 2023: Dr. Bill Morice
December 22, 2022 07:00 - 16 minutes - 23.3 MBWilliam Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, joins “Answers From the Lab” for his weekly leadership update with host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic. In this episode, Drs. Pritt and Morice share their predictions for the new year and discuss why they believe 2023 will be a pivotal year for health care.
The laboratory’s role in spurring innovation: Dr. Bill Morice
December 15, 2022 07:00 - 10 minutes - 14.4 MBWilliam Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, joins “Answers From the Lab” for his weekly leadership update with host Bobbi Pritt, M.D., interim chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic. In this episode, Drs. Pritt and Morice discuss how offering specialty testing for conditions like Stiff-Person Syndrome and Alpha-Gal helps to advance innovation and give patients the answers they need.
Respiratory illness updates and health care economics: Dr. Bill Morice
December 08, 2022 07:00 - 13 minutes - 18.1 MBWilliam Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D., interim chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic. In this episode, Drs. Pritt and Morice provide an update on respiratory illness in the United States and discuss what’s at stake for health care organizations and laboratories in this year’s omnibus spending bill.
Respiratory illness updates and health care economics
December 08, 2022 07:00 - 13 minutes - 18.1 MBWilliam Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D., interim chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic. In this episode, Drs. Pritt and Morice provide an update on respiratory illness in the United States and discuss what’s at stake for health care organizations and laboratories in this year’s omnibus spending bill.
Ensuring quality in the lab: Dr. Bill Morice
December 01, 2022 07:00 - 15 minutes - 21.7 MBWilliam Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, joins “Answers From the Lab” for his weekly leadership update with host Bobbi Pritt, M.D., interim chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic. In this episode, using recent news as an example, Drs. Pritt and Morice discuss what can go wrong if everyone in the lab does not make quality their top priority.
Liquid biopsy offers noninvasive DNA testing for cancer care: Gang Zheng, M.D., Ph.D., and Aaron Mansfield, M.D.
November 29, 2022 07:00 - 11 minutes - 16.4 MB(00:31) Could you each provide us a little bit about yourself and your background? Dr. Zheng, we'll start with you. (01:40) Dr. Mansfield, how about you? (02:07) Could you explain a little bit about the new biopsy test and the technology? (03:58) Which patients should have this testing and when should it be used? (06:44) What alternative test options are available and how would they compare to the Mayo complete cell-free DNA panel? (08:28) Can you go into a little more d...
Staying safe during the holidays: Dr. Bill Morice
November 24, 2022 07:00 - 9 minutes - 12.6 MBWilliam Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D., interim chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic. In this episode, Dr. Pritt and Dr. Morice discuss how to stay healthy during the holiday season and protect yourself and your loved ones from respiratory illnesses including influenza, COVID-19, and respiratory syncytial virus (RSV)....
Carrier Screening: Linda Hasadsri, M.D., Ph.D.
November 22, 2022 07:00 - 12 minutes - 17.4 MB(01:11) Dr. Hasadsri, could you provide us with an overview of what carrier screening is? (02:28) Can you really expand on why these tests are important? (05:25) So in your experience, who could benefit from carrier screening and when should that testing be performed? (06:45) Can you just share how does a healthcare provider order carrier screening and then secondarily what sample types are accepted? (08:05) Can you share what are some of the unique features of our testing that...
The challenges facing most health care leaders: Dr. Bill Morice
November 17, 2022 07:00 - 12 minutes - 17.9 MBWilliam Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D., interim chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic. In this episode, Dr. Pritt and Dr. Morice discuss common challenges facing many hospital and laboratory leaders today, the important role of lab leaders in advancing patient care, and what to watch in Washington, D.C., as we head int...
Novel malabsorption panel speeds diagnosis: Puanani Hopson, D.O.
November 15, 2022 07:00 - 12 minutes - 17.8 MB(00:32) Can you tell us a little bit about yourself, your background and your role at Mayo Clinic? (01:08) How long have you been with Mayo Clinic and where were you previously? (01:37) Can you tell us a little bit about the panel and explain why these four tests were chosen over other combinations of tests? (07:43) Which patients would this panel be used for and when should the panel be run? (09:26) Is there anything else you'd like to explain about this panel?
Legislation, leadership, and MayoComplete: Dr. Bill Morice
November 10, 2022 07:00 - 11 minutes - 16.4 MBWilliam Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D., interim chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic. In this episode, Dr. Pritt and Dr. Morice discuss their new roles at Mayo Clinic and update listeners on the latest legislative news impacting the laboratory and diagnostic industries. They also highlight the launch of MayoComplete, ...
Comprehensive panel boosts GIST diagnosis sensitivity: Rondell Graham, M.B.B.S.
November 08, 2022 07:00 - 8 minutes - 11.9 MB(00:31) Can you please provide us a little bit of background about yourself? (01:29) Can you give us an overview of this assay? (02:44) Can you talk about what genes have been added, and why? (04:16) Can you talk about patients who should have this testing? (06:20) Are there any last comments that you would like to make about the new gastrointestinal tumor panel?
Testing is essential in the months ahead: Dr. Bill Morice
November 03, 2022 06:00 - 9 minutes - 13.5 MBWilliam Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice discuss how traveling and gathering impacts respiratory virus spread, and how testing and lab stewardship will be critical in the months ahead. They also highlight Dr. Pritt’s parasitology blog, Cr...
Melanoma panel provides more tumor information: Ruifeng (Ray) Guo, M.D., Ph.D.
November 01, 2022 06:00 - 11 minutes - 15.4 MB(00:32) Could you provide a little bit of background about yourself? (01:43) Could you give a brief overview of the new melanoma assay? (04:53) Is the assay able to provide diagnostic, prognostic and classification information, and potential therapeutic implications? (05:12) Could you talk a little more about the MSI assessment in this panel? (05:59) Which patients should have this testing? (07:01) How are these results used in patient care? (08:39) Is there anything e...
Colorectal panel provides detailed cancer information: Rondell Graham, M.B.B.S.
October 27, 2022 06:00 - 9 minutes - 13.4 MB(00:32) Could you provide us a little background about yourself? (01:44) Could you give us a brief overview of the new Mayo complete colorectal panel assay? (03:44) Can you go a little bit into more detail on guidelines and therapeutic implications concerning these specific genes? (06:09) Which patients should have this testing? (08:00) Are there any last pieces you'd like to add about the new Mayo Clinic colorectal cancer assay?
Focused lung panel informs the use of targeted cancer therapies: Ying-Chun Lo, M.D., Ph.D.
October 25, 2022 06:00 - 11 minutes - 15.6 MB(00:32) Could you provide us some background about yourself? (01:34) Could you give us a brief overview of the new Mayo complete lung cancer assay? (03:31) Can you talk a little bit more about the specific genes and why they're important for patient care? (04:53) When would a clinician pathologist order a focused NGS panel, such as this new Mayo complete lung cancer panel, over a larger cancer panel? (07:27) What specimens are accepted for the Mayo complete lung cancer pan...
Unique pediatric evaluation targets relevant autoimmune/CNS antibodies: Andrew McKeon, M.B., B.Ch., M.D.
October 18, 2022 06:00 - 16 minutes - 23 MB(00:31) Could you tell us a little bit about yourself and your background? (01:15) Can you give us a little understanding of this disease state and why a tailored evaluation for pediatric patients is important? (02:47) What makes it more challenging to diagnose a pediatric autoimmune neurological disorder? (03:32) Is the tailored evaluation necessary because different antibodies are evaluated? (04:08) How common are these disorders in pediatric patients? (04:40) How does ...
Preparing for respiratory infection season: Dr. Matthew Binnicker
October 13, 2022 06:00 - 8 minutes - 11.2 MBOn this week’s episode of the "Answers From the Lab" podcast, Bobbi Pritt, M.D., is joined by Matthew Binnicker, Ph.D., director of the Clinical Virology Laboratory at Mayo Clinic. Dr. Pritt and Dr. Binnicker discuss why it could be a rough influenza season, testing options for patients with respiratory infections, and how to protect yourself from illness.
Chain of Custody Testing: Loralie Langman, Ph.D.
October 11, 2022 06:00 - 6 minutes - 5.78 MB(0:32) Will you tell us a bit about yourself and your background? (01:35) Can you help us understand what type of tests you perform in your laboratory and how the results can be used to support patient care? (02:18) When is it important to consider urine drug testing, and what is our recommended approach? (03:59) Could you help us understand more about forensic toxicology and when to consider testing? (04:46) Is chain of custody testing recommended for only a sm...
Shifting from pandemic to endemic: Dr. Bill Morice
October 06, 2022 06:00 - 11 minutes - 15.9 MBWilliam Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice discuss the stabilization of monkeypox and COVID-19, the shift from pandemic to endemic status, the increase in global virus outbreaks, and the role that laboratory medicine plays in this changing ...
Virus outlook heading into fall: Dr. Bill Morice
September 29, 2022 06:00 - 11 minutes - 15.3 MBWilliam Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice cover current trends for monkeypox and COVID-19, their thoughts as autumn begins, getting back to infection prevention basics, and a quick legislation update.
Advocating for lab legislation: Dr. Bill Morice
September 22, 2022 06:00 - 10 minutes - 15.2 MBWilliam Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice discuss the Saving Access to Laboratory Services Act (SALSA), how it is designed to mitigate harmful effects of the Protecting Access to Medicare Act (PAMA), where the legislation stands today, and...
PIK3CA assay guides treatment of progressing breast cancer: Katherine Geiersbach, M.D.
September 20, 2022 06:00 - 8 minutes - 11.9 MB(00:32) Could you provide a little bit of background about yourself, please? (01:01) Please give us a brief overview of the new PIK3CA assay. (02:09) Why do we offer two different tests, and when should each be ordered? (03:58) Which patients should have this testing? (04:39) Is this testing used for patients being considered for second-line treatment after first-line hormone receptor treatment? (05:20) Is there anything else you would like to add about the PIK3CA testi...
Leading diagnostics into the future: Dr. Bill Morice
September 19, 2022 06:00 - 13 minutes - 18.3 MBWilliam Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, they discuss Dr. Morice’s new role as CEO and president of Mayo Clinic Laboratories (MCL), his patient-centered vision for the future, and how MCL is leading positive changes in the diagnostics industry.
PCD test provides definitive diagnosis of a rare disease: Joseph Maleszewksi, M.D., and Marie-Christine Aubry, M.D.
September 15, 2022 06:00 - 8 minutes - 12.4 MB(00:31) Could each of you please provide a little bit of background about yourself? (01:18) Let's start with a general definition of primary ciliary dyskinesia (PCD) for our audience. (02:21) PCD is rare. Dr. Maleszewski, can you talk about the implications of that? (02:39) What is the current state of PCD diagnosis in the U.S. and globally, and what are the implications for patient care? (03:37) Can you say a bit more about Mayo Clinic's diagnostic approach to PCD? (05:1...
PCD test provides definitive diagnosis of a rare disease: Joseph Maleszewski, M.D., and Marie-Christine Aubry, M.D.
September 15, 2022 06:00 - 8 minutes - 12.4 MB(00:31) Could each of you please provide a little bit of background about yourself? (01:18) Let's start with a general definition of primary ciliary dyskinesia (PCD) for our audience. (02:21) PCD is rare. Dr. Maleszewski, can you talk about the implications of that? (02:39) What is the current state of PCD diagnosis in the U.S. and globally, and what are the implications for patient care? (03:37) Can you say a bit more about Mayo Clinic's diagnostic approach to PCD? (05:1...
PETH: Paul Jannetto, Ph.D.
September 13, 2022 06:00 - 10 minutes - 9.4 MB(00:32) Would you mind sharing a bit about yourself and your background? (01:44) Would it be fair to say you're an expert on this topic? (01:57) Could you help us understand the role of laboratory testing in supporting recovery from alcohol use disorders, and how to approach testing for those patients? (04:50) Could you help us understand our new direct alcohol biomarker test and its benefits? (07:57) What other tests are available, and how do they compare with this biomar...
Looking at the big picture: Dr. Bill Morice
September 08, 2022 06:00 - 13 minutes - 18.1 MBWilliam Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice discuss current challenges in lab medicine and what it means to be a laboratory leader, including innovation, test stewardship, and the use of digital pathology.
Precision therapeutics can individualize depression treatment: Ann Moyer, M.D., Ph.D., and Paul Jannetto, Ph.D.
September 06, 2022 06:00 - 18 minutes - 25.7 MB(00:31) Can you both tell us a little bit about yourselves and your backgrounds? Dr. Moyer, do you want to start? (01:51) Your background, Dr. Janetto? (02:47) Please provide an overview of major depressive disorder and the test that Mayo Clinic Laboratories has available for therapeutic drug monitoring as well as pharmacogenomics. (07:05) Which patients should have this testing, and when should it be performed? (11:33) What alternative test options are available, and how...
State-of-the-art genetics panel optimizes kidney disease treatment: Linnea M. Baudhuin, Ph.D., and Emily K. Thoreson, M.S., CGC
August 30, 2022 06:01 - 11 minutes - 16 MB(00:31) Would each of you share a little about yourselves and your backgrounds? (01:17) Could you please provide us with an overview of what types of genetic testing for inherited kidney diseases are available Mayo Clinic Labs? (02:35) Can you expand on why genetic testing for kidney disease is important? (04:30) Who could benefit from genetic testing for inherited kidney diseases? (05:55) What types of variants are detected by these new genetic panels at Mayo Clinic Labs?...
Focused screening yields cost-effective prenatal information: Linda Hasadsri, M.D., Ph.D.
August 30, 2022 06:00 - 14 minutes - 13.5 MB(00:31) Could you provide us a little bit about your background? (01:09) Can you give us an overview of the carrier screening panels that have been developed and the focused panel for carrier screening? (07:53) When should this focused panel testing be performed? (09:41) Can you share a little bit more detail about what the testing is like for families that choose that route? (11:06) Can you expand on what alternative test options are available and how these tests compare?...
Monkeypox and legislation updates: Dr. Bill Morice
August 25, 2022 06:00 - 14 minutes - 20.3 MBWilliam Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice discuss the latest monkeypox developments, potential scenarios for monkeypox moving forward, and where the VALID Act stands.
CIDP: Divyanshu (Div) Dubey, M.B.B.S.
August 23, 2022 06:00 - 22 minutes - 21.1 MB(00:32) Would you mind telling our listeners a little about yourself and your background? (01:16) This evaluation is about CIDP — chronic inflammatory demyelinating polyneuropathy, correct? (02:16) Can you give us an overview of what the CIDP evaluation will consist of? (04:38) Our standalone test for neurofascin-155 won't change, but will be rolled into this new test along with contactin-1, correct? (06:41) This is a very rare disease with subtle clues, so doe...
Ongoing evolution of monkeypox: Dr. Bill Morice
August 18, 2022 06:00 - 13 minutes - 18.1 MBWilliam Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice discuss how monkeypox can be transmitted, the possibilities of a future Emergency Use Authorization (EUA), and access to testing.
PMND1: John Lieske, M.D.
August 16, 2022 06:00 - 8 minutes - 7.83 MB(00:31) Could you tell us a bit about yourself and your background? (01:11) Could you describe these new tests and when it would be appropriate to use each of them in the clinic? (03:16) Could you provide a little background on why MCL is making changes to the PLA2R test? (04:34) Could you describe the change to KDIGO guidelines and when it may be appropriate to skip the biopsy? How will these new tests help physicians implement these new guidelines in their practices?
Monkeypox testing progress: Dr. Bill Morice
August 11, 2022 06:00 - 10 minutes - 15 MBWilliam Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice discuss new developments in monkeypox testing, updates on the federal response, and lessons learned from managing other viruses.
Enhanced detection of genetic mutation to optimize leukemia treatment: Rong He, M.D.
August 09, 2022 06:00 - 19 minutes - 27.1 MB(00:32) Could you please provide a bit about yourself and your background? (01:39) Could you please give a basic overview of the NPM1Q test and why we are so pleased to offer it? (06:56) Which patients should have this test and when should it be performed? Is it when they are initially diagnosed? (09:44) How would translocation 8;21 and inversion 16 tests be incorporated into testing for patients? (10:41) How are the results used in patient care? (13:41) What alternative...